These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34986906)

  • 1. Occupational exposure to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and risk of infection among healthcare personnel.
    Shah VP; Breeher LE; Alleckson JM; Rivers DG; Wang Z; Stratton ER; Farah W; Hainy CM; Swift MD
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1785-1789. PubMed ID: 34986906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coworkers are more likely than patients to transmit SARS-CoV-2 infection to healthcare personnel.
    Farah W; Breeher L; Shah V; Wang Z; Hainy C; Swift M
    Occup Environ Med; 2022 Oct; 79(10):713-716. PubMed ID: 35927001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study.
    Howard-Anderson JR; Adams C; Dube WC; Smith TC; Sherman AC; Edupuganti N; Mendez M; Chea N; Magill SS; Espinoza DO; Zhu Y; Phadke VK; Edupuganti S; Steinberg JP; Lopman BA; Jacob JT; Fridkin SK; Collins MH
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1664-1671. PubMed ID: 35156597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of healthcare personnel exposures to patients with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) associated with personal protective equipment.
    Shah VP; Breeher LE; Hainy CM; Swift MD
    Infect Control Hosp Epidemiol; 2022 Jun; 43(6):770-774. PubMed ID: 33975656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Exposure and Infection Among Health Care Personnel - Minnesota, March 6-July 11, 2020.
    Fell A; Beaudoin A; D'Heilly P; Mumm E; Cole C; Tourdot L; Ruhland A; Klumb C; Rounds J; Bailey B; Liverseed G; Peterson M; Mahoehney JP; Ireland M; Bye M; Setty S; Leeds M; Taylor J; Holzbauer S; ;
    MMWR Morb Mortal Wkly Rep; 2020 Oct; 69(43):1605-1610. PubMed ID: 33119557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
    Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
    JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System.
    Baker JM; Nelson KN; Overton E; Lopman BA; Lash TL; Photakis M; Jacob JT; Roback JD; Fridkin SK; Steinberg JP
    Ann Intern Med; 2021 May; 174(5):649-654. PubMed ID: 33513035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and occupational risk factors for coronavirus disease 2019 (COVID-19) in healthcare personnel.
    Kwon JH; Budge PJ; O'Neil CA; Peacock K; Aagaard EM; Fraser VJ; Olsen MA; Babcock H;
    Antimicrob Steward Healthc Epidemiol; 2022; 2(1):e123. PubMed ID: 36505949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Infection in Healthcare Personnel With High-risk Occupational Exposure: Evaluation of 7-Day Exclusion From Work Policy.
    Maltezou HC; Dedoukou X; Tseroni M; Tsonou P; Raftopoulos V; Papadima K; Mouratidou E; Poufta S; Panagiotakopoulos G; Hatzigeorgiou D; Sipsas N
    Clin Infect Dis; 2020 Dec; 71(12):3182-3187. PubMed ID: 32594160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral Sequencing to Investigate Sources of SARS-CoV-2 Infection in US Healthcare Personnel.
    Braun KM; Moreno GK; Buys A; Somsen ED; Bobholz M; Accola MA; Anderson L; Rehrauer WM; Baker DA; Safdar N; Lepak AJ; O'Connor DH; Friedrich TC
    Clin Infect Dis; 2021 Sep; 73(6):e1329-e1336. PubMed ID: 33857303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic.
    Rosser JI; Röltgen K; Dymock M; Shepard J; Martin A; Hogan CA; Blomkalns A; Mathew R; Parsonnet J; Pinsky BA; Maldonado YA; Boyd SD; Chang SI; Holubar M;
    Infect Control Hosp Epidemiol; 2021 Sep; 42(9):1053-1059. PubMed ID: 33292895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of serial testing to interrupt a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) outbreak on a hospital medical floor-Minnesota, October-December 2020.
    Prabhu RM; Firestone MJ; Bergman KL; Beaudoin AL; Hale T; Lorentz AJ; Garfin J; Wang X; Holzbauer SM
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):427-432. PubMed ID: 35225190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The front-line during the coronavirus disease 2019 pandemic: healthcare personnel.
    Kang M; Perl TM
    Curr Opin Infect Dis; 2021 Aug; 34(4):372-383. PubMed ID: 34227581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for SARS-CoV-2 Infection Among US Healthcare Personnel, May-December 2020.
    Chea N; Brown CJ; Eure T; Ramirez RA; Blazek G; Penna AR; Li R; Czaja CA; Johnston H; Barter D; Miller BF; Angell K; Marshall KE; Fell A; Lovett S; Lim S; Lynfield R; Davis SS; Phipps EC; Sievers M; Dumyati G; Concannon C; McCullough K; Woods A; Seshadri S; Myers C; Pierce R; Ocampo VLS; Guzman-Cottrill JA; Escutia G; Samper M; Thompson ND; Magill SS; Grigg CT
    Emerg Infect Dis; 2022 Jan; 28(1):95-103. PubMed ID: 34856114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among employees of a US academic children's hospital during coronavirus disease 2019 (COVID-19) pandemic.
    Fisher BT; Sharova A; Boge CLK; Gouma S; Kamrin A; Blumenstock J; Shuster S; Gianchetti L; Collins D; Akaho E; Weirick ME; McAllister CM; Bolton MJ; Arevalo CP; Goodwin EC; Anderson EM; Christensen SR; Balamuth F; John ARO; Li Y; Coffin S; Gerber JS; Hensley SE
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1647-1655. PubMed ID: 34852866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure Outcomes in Fully Vaccinated Healthcare Personnel With Known Severe Acute Respiratory Syndrome Coronavirus 2 Exposure-Minnesota, January-August 2021.
    Ruhland A; Fell A; Holzbauer SM; D'Heilly P; Curtis K; Wick H; Friedman B; Mumm E; Ireland M; Estey-Dix C; Betts-Roelike M; Beaudoin A
    Clin Infect Dis; 2022 Dec; 75(12):2247-2249. PubMed ID: 35684998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sources of coronavirus disease 2019 (COVID-19) exposure among healthcare personnel (HCP) in a large tertiary-care medical center.
    Shaw J; Suits P; Steigerwald H; Thomas SJ; Formica MK
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e85. PubMed ID: 37179763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occupational COVID-19 exposures and secondary cases among healthcare personnel.
    Ibiebele J; Silkaitis C; Dolgin G; Bolon M; JaneCullen ; Zembower T
    Am J Infect Control; 2021 Oct; 49(10):1334-1336. PubMed ID: 34375702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission risk of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) to healthcare personnel following unanticipated exposure to aerosol-generating procedures: Experience from epidemiologic investigations at an academic medical center.
    Fawcett SE; Madhusudhan MS; Gaddam EN; Almario MJ; Masih SR; Klute-Evans DD; Johnson JC; Stroud CD; Dolan-Caren JA; Ben-Aderet MA; Luria J; Morgan MA; Vail E; Grein JD
    Infect Control Hosp Epidemiol; 2023 Feb; 44(2):325-327. PubMed ID: 34725006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.